Ganaxolone Expanded Access Program Compassionate Use

Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)

NCT05757544 ·Status: WITHDRAWN ·Phase: PHASE2

Open-label Extension to Protocol 1042-0600

NCT00512317 ·Status: COMPLETED ·Phase: PHASE2

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

NCT05323734 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

NCT03350035 ·Status: COMPLETED ·Phase: PHASE2

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B)

NCT04285346 ·Status: COMPLETED ·Phase: PHASE2

Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies

NCT02358538 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

NCT05814523 ·Status: WITHDRAWN ·Phase: PHASE3

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

NCT00465517 ·Status: COMPLETED ·Phase: PHASE2

Randomized Therapy In Status Epilepticus

NCT04391569 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

NCT01963208 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

NCT05064878 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome

NCT00236756 ·Status: COMPLETED ·Phase: PHASE3

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

NCT03559673 ·Status: NO_LONGER_AVAILABLE

Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy

NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2

RNS System RESPONSE Study

NCT04839601 ·Status: TERMINATED ·Phase: NA

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

NCT03355209 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT04686786 ·Status: TERMINATED ·Phase: PHASE2

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

NCT02318537 ·Status: WITHDRAWN ·Phase: PHASE3

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

NCT02834793 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies

NCT03166215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

NCT00236704 ·Status: COMPLETED ·Phase: PHASE3

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

NCT03865732 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

NCT00275925 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy

NCT02332447 ·Status: COMPLETED ·Phase: PHASE3